UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Details
Sales, net	$ 10,902	$ 10,732
Cost of goods sold	4,066	3,959
Gross profit	6,836	6,773
Operating expense
Selling, general and administrative	2,838	2,557
Research & development	135	115
Total operating expenses	2,973	2,672
Operating income	3,863	4,101
Other income	125	36
Income before provision for income taxes	3,988	4,137
Provision for income taxes	848	998
Net income	$ 3,140	$ 3,139
Earnings per common share (basic)	$ 0.85	$ 0.84
Earnings per common share (diluted)	$ 0.84	$ 0.84
Shares outstanding (basic)	3,707	3,722
Shares outstanding (diluted)	3,724	3,738
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ (2,449)	$ 948
Total comprehensive income	$ 691	$ 4,087